Ipca Laboratories Limited Receivables

Ipca Laboratories Limited (IPCALAB.NS) currently reports a receivables of $21B as of March 2026. That compares with $19B in the prior-year period — up 7.7% year over year. Use the charts on this page to explore Ipca Laboratories Limited's receivables history and peer comparisons.

Ipca Laboratories Limited's receivables increased from $19B to $21B — a 7.7% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ipca Laboratories Limited reported $21B in receivables as of March 2026. That compares with $19B in the prior-year period — up 7.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $21B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ipca Laboratories Limited, and consider following IPCALAB.NS for alerts when major investors trade the stock.